ESMO Asia 2015 Congress

Oncology Meeting Resources

18 Dec - 21 Dec 2015, Singapore

ESMO Asia 2015

The ESMO Asia Congress comprised both scientific and educational tracks prepared by an international scientific committee. There was a strong emphasis on state of the art science, including a call for abstracts, and the current standard of care across all major tumour types.

Abstracts, presentations and webcasts from the ESMO Asia 2015 Congress are now available here to ESMO members. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful Links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...ngress/Welcome-address-by-the-ESMO-President

Date: 18 Dec 2015
Presenter: Rolf A. Stahel
Resources: Presentation, Webcast

http://oncologypro.esmo.org/Meeting-Resourc...-Lung-cancer-From-nihilism-to-great-advances

Date: 18 Dec 2015
Presenter: Frances Shepherd
Resources: Presentation, Webcast
Topic: Lung and other Thoracic Tumours

http://oncologypro.esmo.org/Meeting-Resourc...ecture-Cancer-immunotherapy-by-PD-1-blockade

Disclosure

Date: 18 Dec 2015
Presenter: Tasuku Honjo
Resources: Abstract, Presentation, Webcast
Topics: Melanoma and other Skin Tumours, Pathology/Molecular Biology

http://oncologypro.esmo.org/Meeting-Resourc...015-Congress/Angiogenesis-in-gastric-cancers

Date: 18 Dec 2015
Presenter: Andrés Cervantes
Resources: Presentation, Webcast
Topics: Gastric Cancer, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...-and-the-challenge-of-identifying-biomarkers

Date: 18 Dec 2015
Presenter: Annette Byrne
Resources: Presentation, Webcast
Topic: Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...cinoma-Interim-results-from-a-phase-1b-study

Aim/BackgroundNasopharyngeal carcinoma (NPC) exhibits high expression of PD-1, and expression of PD-1/PD-L1 correlated with poor outcome. Pembrolizumab is a potent, highly selective, humanized monoclonal...

Date: 18 Dec 2015
Presenter: Chiun Hsu
Resources: Abstract, Presentation, Webcast
Topics: Cancer Immunology and Immunotherapy, Head and Neck Cancers

http://oncologypro.esmo.org/Meeting-Resourc...-Congress/Pregnancy-during-endocrine-therapy

Date: 18 Dec 2015
Presenter: Sibylle Loibl
Resources: Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Breast Cancer, Early Stage, Cancer in Pregnancy

http://oncologypro.esmo.org/Meeting-Resourc...sion-vs-pseudoresponse-and-pseudoprogression

Date: 18 Dec 2015
Presenter: Ke Sai
Resources: Presentation, Webcast
Topics: Central Nervous System Malignancies, Imaging, Diagnosis and Staging

http://oncologypro.esmo.org/Meeting-Resourc...ker-analysis-of-LUX-head-and-neck-1-LUX-H-N1

Aim/BackgroundIn the Phase III LUX-H&N1 trial, afatinib, an irreversible ErbB family blocker, significantly improved progression-free survival (PFS) vs MTX (median 2.6 vs 1.7 mos; HR 0.80; p = 0.

Date: 18 Dec 2015
Presenter: Makoto Tahara
Resources: Abstract, Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Head and Neck Cancers

http://oncologypro.esmo.org/Meeting-Resourc...ne-therapy-and-modality-of-patient-selection

Date: 18 Dec 2015
Presenter: Sung Bae Kim
Resources: Presentation, Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Breast Cancer, Early Stage, Personalised Medicine